EUVIMEDEUVIMED entdecken
Studienprotokoll

Improving Access to Dementia Care in the Era of Monoclonal Antibody Treatments for Alzheimer’s Disease: a Pilot Clinical Protocol Using Abbreviated Neuropsychological Assessment

Savana M Naini iD, Ryan C Thompson iD, Maria Agustina Rossetti iD, Virginia T Gallagher iD, Carol A Manning iD, Kathleen Fuchs iD, Anelyssa D'Abreu iD, Tanya Prachar iD, Shannon E Reilly iD

Archives of Clinical Neuropsychology · 2025

DOI: 10.1093/arclin/acae111 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift Archives of Clinical Neuropsychology, 2025. Verfasst von Savana M Naini und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University of Virginia School of Medicine, 1215 Lee Street, Charlottesville, VA 22903, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Neuropsychological Tests, Cognitive Dysfunction, Health Services Accessibility. Die Arbeit nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To meet the growing demand for timely diagnosis in the new era of disease-modifying medications for Alzheimer’s disease (AD), the present study aimed to reduce clinic wait times by developing and refining an abbreviated neuropsychological battery to assess individuals with a suspected amnestic process (i.e., Early-Stage AD Pathway).

Method

Early-Stage AD Pathway patients were referred by an internal neurology provider who determined that the patient had: (1) an amnestic clinical presentation, (2) a normal neurological examination, and (3) a Montreal Cognitive Assessment total score between 18 and 25. These patients were scheduled for a 2-h neuropsychological evaluation, including a brief clinical interview and an abbreviated testing battery. We evaluated n = 19 patients in the Early-Stage AD Pathway and compared them to 114 older adults referred via traditional clinic procedures (i.e., General Clinic).

Results

Most individuals evaluated via the Early-Stage AD Pathway were diagnosed with mild cognitive impairment (MCI; 68.4%) or mild dementia (21.1%) through the neuropsychological evaluation. Rate of diagnosis of MCI/dementia was comparable between groups. The average number of days between initial referral and completion of the neuropsychological evaluation was significantly lower (Mdiff = 145.8 days, U = 1867.500, p < 0.001) for the Early-Stage AD Pathway group than for the General Clinic group, as the former could be scheduled more flexibly.

Conclusions

Implementing an abbreviated neuropsychological assessment process significantly reduced the time between referral and evaluation to identify individuals who may be eligible for emerging pharmacological treatments for AD and/or non-pharmacological interventions in a timely manner.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseNeuropsychological TestsCognitive DysfunctionHealth Services AccessibilityDementiaHumansFemaleMaleAgedPilot ProjectsAged, 80 and overMiddle Aged

Stichwörter der Autor:innen

Alzheimer’s diseaseCognitive assessmentDementiaMild cognitive impairment

Autor:innen und Institutionen

  • Department of Neurology, University of Virginia School of Medicine, 1215 Lee Street, Charlottesville, VA 22903, USA.

ORCID-Profile: Savana M Naini, Ryan C Thompson, Maria Agustina Rossetti, Virginia T Gallagher, Carol A Manning, Kathleen Fuchs, Anelyssa D'Abreu, Tanya Prachar, Shannon E Reilly

Zitieren

APA

Naini, S. M., Thompson, R. C., Rossetti, M. A., Gallagher, V. T., Manning, C. A., Fuchs, K., D'Abreu, A., Prachar, T., & Reilly, S. E. (2025). Improving Access to Dementia Care in the Era of Monoclonal Antibody Treatments for Alzheimer’s Disease: a Pilot Clinical Protocol Using Abbreviated Neuropsychological Assessment. Archives of Clinical Neuropsychology. https://doi.org/10.1093/arclin/acae111

Vancouver

Naini SM, Thompson RC, Rossetti MA, Gallagher VT, Manning CA, Fuchs K, et al. Improving Access to Dementia Care in the Era of Monoclonal Antibody Treatments for Alzheimer’s Disease: a Pilot Clinical Protocol Using Abbreviated Neuropsychological Assessment. Archives of Clinical Neuropsychology. 2025. doi:10.1093/arclin/acae111

BibTeX
@article{Naini2025,
  author = {Naini, Savana M and Thompson, Ryan C and Rossetti, Maria Agustina and Gallagher, Virginia T and Manning, Carol A and Fuchs, Kathleen and D'Abreu, Anelyssa and Prachar, Tanya and Reilly, Shannon E},
  title = {Improving Access to Dementia Care in the Era of Monoclonal Antibody Treatments for Alzheimer’s Disease: a Pilot Clinical Protocol Using Abbreviated Neuropsychological Assessment},
  journal = {Archives of Clinical Neuropsychology},
  year = {2025},
  doi = {10.1093/arclin/acae111}
}
Kostenlos starten →